Novel Approaches to Diagnosing Pulmonary Diseases

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Overview
• Disease Overview
  • Infectious Respiratory Disease
  • Obstructive Lung Disease
  • Lung Cancer
• Current Diagnostics for Pulmonary Diseases
  • Infectious Respiratory Disease
  • Obstructive Respiratory Disease
  • Lung Cancer
• Novel Biomarkers in Pulmonary Diseases
  • Biomarker for Respiratory Tract Infection
  • Novel Exhaled Biomarker in Obstructive Lung Disease
  • Biomarkers for Use with Therapeutics for Non-Small-Cell Lung Cancer
• New Technologies for Infectious Respiratory Diagnosis
  • Multiplex Assays
  • Microarrays
• Key Players in Infectious Respiratory Diagnostics
  • Becton Dickinson
  • CombiMatrix
  • Genaco Biomedical Products
  • Inverness Medical Innovations
  • Luminex/Tm Bioscience
  • Prodesse
  • Quidel
  • Remel
  • ZymeTx
• Key Players in Innovative Diagnostics for Lung Cancer
  • 20/20 Gene Systems
  • Epigenomics
  • Genzyme Genetics
  • Monogram Biosciences
  • Rosetta Genomics
• Outlook
  • Viral Respiratory Disease
  • Obstructive Lung Disease
  • Lung Cancer

Spectrum Expert Commentary

• Differential Diagnosis of Asthma and COPD: Increase PCP Awareness for Accurate Diagnosis and Optimal Treatment

Tables

• 1. Pulmonary Diseases Covered in This Report
• 2. Diagnostics Currently Available for Viral Respiratory Diseases
• 3. Select Companies Marketing Pulmonary Diagnostic Devices for COPD, Asthma, and Emphysema
• 4. Novel Biomarkers for Diagnosis/Prognosis of Pulmonary Diseases
• 5. Select Companies Developing Innovative Diagnostics for Lung Cancer
• 6. Select Companies with Rapid Diagnostic Products for Viral Respiratory Diseases
• 7. Molecular Diagnostics for Detection of Multiple Respiratory Viruses

Figures

• 1. Common Infectious Respiratory Diseases
• 2. Non-Small-Cell Lung Cancer Risk Factors
• 3. Improvements in COPD Diagnosis Is a Clear Unmet Need